Agenda for the November 2015 PBAC meeting

26 August 2015 - The agenda for the November 2015 PBAC meeting is now available. ...

Read more →

Changes to growth hormone and botulinum toxin s100 programs

26 August 2015 - Updated frequently asked questions have been prepared that provide further detail on the 1 September 2015 changes ...

Read more →

PBAC Guidelines review – extension of public consultation

25 August 2015 - The Items for inclusion in the PBAC Guidelines Review are now published on the PBS website. ...

Read more →

Meet the health crusader saving lives with cheap drugs

20 August 2015 - A Tasmanian man with hepatitis C is taking on a global pharmaceutical company for what he says ...

Read more →

Drug companies and patient groups want faster approval for cancer drugs

Patient groups are calling for changes to fast track the approval and subsidy of cancer medicines, saying cancer sufferers haven't got ...

Read more →

Changes to certain s100 programs

Frequently Asked Questions have been prepared that outline changes to certain Section 100 programmes under the PBS. Changes to some s100 ...

Read more →

Pharmaceutical Benefits Scheme listing of Kalydeco (ivacaftor)

[:content [\1 \7 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \K \a \l \y \d \e \c \o \  \( \i \v \a \c \a \f \t \o \r \) \space \w \a \s \space \r \e \g \i \s \t \e \r \e \d \space \o \n \space \t \h \e \space \A \u \s \t \r \a \l \i \a \n \space \R \e \g \i \s \t \e \r \space \o \f \space \T \h \e \r \a \p \e \u \t \i \c \space \G \o \o \d \s \space \o \n \space \9 \space \J \u \l \y \space \2 \0 \1 \3 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t " ..."]]
Read more →

Outcomes for the diabetes post-market review

The Minister for Health has considered the reports for all three stages of the post-market review of products used in ...

Read more →

DUSC Utilisation Analysis Public Release Documents - February 2015

The Public Release Documents from the February 2015 Drug Utilisation SubCommittee meeting are now available on the PBS website. ...

Read more →

Spain to guarantee government's payments to drugmakers, report suggests

[:content [\S \p \a \i \n \space \w \i \l \l \space \n \o \w \space \g \u \a \r \a \n \t \e \e \space \r \e \g \i \o \n \a \l \space \g \o \v \e \r \n \m \e \n \t \s \' \space \p \a \y \m \e \n \t \s \space \t \o \space \d \r \u \g \m \a \k \e \r \s \space \i \n \space \a \space \b \i \d \space \t \o \space \g \a \r \n \e \r \space \s \u \p \p \o \r \t \space \f \o \r \space \a \space \p \l \a \n \space \t \o \space \c \e \n \t \r \a \l \i \s \e " ..."]]
Read more →

Schedule of Pharmaceutical Benefits - 1 October 2014

The 1 October 2014 issue of the Schedule of Pharmaceutical Benefits is now available.   The schedule contains a number of ...

Read more →

Sixth Community Pharmacy Agreement delivers for patients

The Pharmacy Guild of Australia welcomes the signing of the Sixth Community Pharmacy Agreement, which underpins the timely and equitable ...

Read more →

NICE consults on draft guidance on the drug simeprevir sodium (Olysio) for treating hepatitis C

In draft guidance published today healthcare guidance body NICE has recommended simeprevir sodium (Olysio, Janssen) as a treatment option for ...

Read more →

Australians may pay more for medicines under trade deal

Australians could be forced to pay more for medicines, movies, computer games and software, and see whistleblowers and journalists prosecuted ...

Read more →

Improved specificity with respect to disease/condition

From time to time, the PBAC has recommended the listing of a new strength or new formulation of a given ...

Read more →